<DOC>
	<DOCNO>NCT01048398</DOCNO>
	<brief_summary>BACKGROUND : Between 3-4 % pregnancy carry term , fetuses breech presentation . The external version maneuver gynecological use turn breech cephalic presentation . For treatment pain suggest use μ agonist remifentanil fast action elimination . OBJECTIVE : To compare effectiveness remifentanil pain management external version . PATIENTS : Pregnant 36 week breech presentation meet inclusion criterion sign consent . Participants randomize two group procedure . Group intervention : paracetamol remifentanil Control group : paracetamol placebo DETERMINATIONS : VAS pain level , percentage success maneuver adverse event . Statistical Analysis : Comparison pain record VAS group comparison adverse event</brief_summary>
	<brief_title>Remifentanil Versus Paracetamol Pain Treatment External Cephalic Versions .</brief_title>
	<detailed_description />
	<mesh_term>Breech Presentation</mesh_term>
	<mesh_term>Remifentanil</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>Fetuses week 36 41 gestation confirm ultrasound noncephalic presentation . Informed consent sign mother legal representative absence . Fetal anomaly Severe hypertension Allergy drug use test Amniotic fluid index ≥ 5 cm Contraindication vaginal delivery Uterine abnormality impair coagulation Placenta previa Rh sensitization Multiple gestation Ruptured membrane Premature detachment normally insert placenta The mother great weight 85kg</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>ceophalic version</keyword>
	<keyword>breech presentation</keyword>
	<keyword>pregnancy</keyword>
	<keyword>remifentanil</keyword>
	<keyword>paracetamol</keyword>
</DOC>